Oliver Krigslund

5PUBLICATIONS
21CO-AUTHORS
Biomedical imagingMolecular targetsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 10, 2025
Targeting uPARAP with an Antibody-Drug Conjugate Exhibits Efficacy against Mesothelioma and Synergizes with Cisplatin.

Pınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang

|Jul 16, 2025
The Recycling Collagen Receptor uPARAP Is a Unique Mediator of Stromal Drug Delivery to Carcinoma Cells.

Kirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen

|Jan 25, 2025
A HER2 Specific Nanobody-Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models.

Anders H Hansen, Kasper I H Andersen, Li Xin

|Jan 17, 2025
Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models.

Virginia Metrangolo, Michaela Hansen Blomquist, Ananya Dutta

|Nov 13, 2021
The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target.

Pınar Çakılkaya, Rikke Raagaard Sørensen, Henrik Jessen Jürgensen

Pageof 1

Frequent Collaborators

5 joint publications

Lars Henning Engelholm

4 joint publications

Henrik Jessen Jürgensen

4 joint publications

Henrik Gårdsvoll

3 joint publications

Pınar Çakılkaya